Valneva SE (VALN)
NASDAQ: VALN · Real-Time Price · USD
10.52
-0.59 (-5.31%)
At close: Mar 6, 2026, 4:00 PM EST
10.00
-0.52 (-4.94%)
After-hours: Mar 6, 2026, 6:47 PM EST
Valneva SE Employees
Valneva SE had 713 employees as of December 31, 2024. The number of employees increased by 37 or 5.47% compared to the previous year.
Employees
713
Change (1Y)
37
Growth (1Y)
5.47%
Revenue / Employee
$301,557
Profits / Employee
-$171,234
Market Cap
920.15M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,300 |
| Maravai LifeSciences Holdings | 550 |
| Arvinas | 246 |
| Geron | 229 |
| uniQure | 209 |
| ARS Pharmaceuticals | 167 |
| Cullinan Therapeutics | 111 |
| Arbutus Biopharma | 44 |
VALN News
- 1 day ago - VALNEVA Declaration of shares and voting rights: February 28, 2026 - GlobeNewsWire
- 5 days ago - Valneva to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 17 days ago - Valneva Reports Preliminary Unaudited 2025 Revenue and Cash and Provides 2026 Outlook - Wallstreet:Online
- 17 days ago - Valneva Reports Preliminary Unaudited 2025 Revenue and Cash and Provides 2026 Outlook - GlobeNewsWire
- 22 days ago - Valneva Provides Update on Recommendations for Use of IXCHIQ in the United Kingdom - Wallstreet:Online
- 22 days ago - Valneva Provides Update on Recommendations for Use of IXCHIQ® in the United Kingdom - GlobeNewsWire
- 4 weeks ago - VALNEVA Declaration of shares and voting rights: January 31, 2026 - GlobeNewsWire
- 4 weeks ago - Valneva and Instituto Butantan Announce Initiation of a Pilot Vaccination Campaign in Brazil with Single-Shot Chikungunya Vaccine IXCHIQ - Wallstreet:Online